Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Aki Shiozawa"'
2
Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records
Autor: Barbara DePree, Katherine Houghton, Aki Shiozawa, Elizabeth Esterberg, Deanna D. King, Janet Kim, Shayna Mancuso
Publikováno v: Menopause. 30:70-79
The aim of this study was to generate real-world evidence documenting use of prescription and nonprescription therapies recorded by health care providers for women experiencing vasomotor symptoms (VMS) associated with menopause.This noninterventional
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42d1376975983c0e10e6ffb0848ae66
https://doi.org/10.1097/gme.0000000000002095
Zobrazit plný text záznamu
3
A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
Autor: David Walker, Aki Shiozawa, Lisa Hines, Noll L. Campbell, Amy Lockefeer, Andrew J. Epstein
Publikováno v: Drugs & Aging
Background and Objective Antimuscarinics, drugs with anticholinergic properties, are frequently prescribed for overactive bladder, and anticholinergic burden is associated with adverse events. The “Polypharmacy: Use of Multiple Anticholinergic Medi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d803b9acbf3f81ba442dba103bfac3c0
https://doi.org/10.1007/s40266-021-00901-2
Zobrazit plný text záznamu
4
Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief report
Autor: Risa Kagan, Aki Shiozawa, Andrew J. Epstein, Robert Espinosa
Publikováno v: Menopause (New York, N.y.)
Objective: Menopause is associated with an increased prevalence of sleep difficulties. We evaluated the economic burden of sleep disturbances among working midlife women. Methods: This retrospective, longitudinal cohort study collected data from the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6526b633e6cbfd510ee9346ef1d95d
https://doi.org/10.1097/gme.0000000000001834
Zobrazit plný text záznamu
5
Higher Resource Utilization and Costs in Long-Term Nursing Home Residents With Overactive Bladder: A Retrospective Study of Medicare Beneficiaries
Autor: S.D. Sura, Aki Shiozawa, Rajender R. Aparasu, Daniel Ng
Publikováno v: Journal of the American Medical Directors Association. 22:1300-1306
OBJECTIVES To determine the all-cause health care resource utilization and costs among long-term nursing home (LTNH) residents with and without overactive bladder (OAB). DESIGN Retrospective cohort study. SETTING AND PARTICIPANTS Minimum Data Set (MD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::700b1f5870b378249a9f192e43a2ce0e
https://doi.org/10.1016/j.jamda.2020.08.037
Zobrazit plný text záznamu
6
Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis
Autor: Aki Shiozawa, Matthias Stoelzel, Sari Hopson, John Hairston, Daniel Ng, Rupali Fuldeore
Publikováno v: Advances in Therapy
Introduction This study sought to compare healthcare resource utilization (HCRU), costs, and workplace productivity among patients with depression, with and without overactive bladder (OAB). Methods This retrospective, case–control cohort analysis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6fbed13d69ac5fcc066a7a3d38658c
https://doi.org/10.1007/s12325-020-01485-w
Zobrazit plný text záznamu
7
Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression
Autor: Si-Tien Wang, Scott J. Johnson, Aki Shiozawa, Ian M. Anderson, Dominic Mitchell
Publikováno v: ClinicoEconomics and Outcomes Research. 11:257-270
Background Patients with treatment-resistant major depressive disorder (TRD) have limited treatment options. We developed an early stage cost-effectiveness model of TRD to explore the potential value of a hypothetical monotherapy relative to the stan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cf17049ee5a20016ed4eb4d4d8ec44ee
https://doi.org/10.2147/ceor.s181718
Zobrazit plný text záznamu
9
Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data
Autor: Aki Shiozawa, Izumi Kawachi, Mieko Ogino, Shuichi Okamoto, Hiroyuki Ota, Shinzo Hiroi
Publikováno v: Neurodegenerative Disease Management. 8:97-103
Aim: Use real-world data to investigate the treatment, comorbidities and prevalence of multiple sclerosis (MS) in an employed Japanese population. Methods: Data from the Japanese Medical Data Center health insurance claims database were analyzed (Jan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1611599806600209f1d0251cea2b44e
https://doi.org/10.2217/nmt-2017-0047
Zobrazit plný text záznamu
10
Serum uric acid levels and the risk of flares among gout patients in a US managed care setting
Autor: Erin K Buysman, Stephanie Korrer, Aki Shiozawa
Publikováno v: Current Medical Research and Opinion. 33:117-124
Serum uric acid (sUA) levels are causally associated with the risk of gout flares. Our aim was to assess the magnitude of the association and time to first flare among patients in a managed care setting.We conducted a retrospective cohort study using
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b04b45a855a1e8c82aa80c82289aa8
https://doi.org/10.1080/03007995.2016.1239193
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje